Fertility and Sterility
Volume 92, Issue 1 , Pages 54-60 , July 2009

Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population

Received 26 March 2008 ,Revised 30 April 2008 ,Accepted 30 April 2008.

References 

  1. Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility. Fertil Steril. 2004;82:40–45
  2. Simpson JL, Elias S, Malinak LR, Buttram VC. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol. 1980;137:327–331
  3. Kennedy S. Is there a genetic basis to endometriosis?. Seminin Reprod Endocrinol. 1997;15:309–318
  4. Kennedy S. The genetics of endometriosis. Eur J Obstet Gynecol Reprod Biol. 1999;82:129–133
  5. Lin J, Zhang X, Chen Y. Mutagen sensitivity as a susceptibility marker for endometriosis. Hum Reprod. 2003;18:2052–2057
  6. Lin J, Zhang X, Qian Y, Ye Y, Shi Y, Xu K, et al. Glutathione S-transferase m1 and t1 genotypes and endometriosis risk: a case-controlled study. Chin Med J (Engl). 2003;116:777–780
  7. Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh LS, Lin CC. Polymorphism for transforming growth factor beta 1-509 (TGF-b1-509): association with endometriosis. Biochem Genet. 2005;43:203–210
  8. Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML, Petraglia F. Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil Steril. 2006;85:764–766
  9. Renner SP, Strick R, Oppelt P, Fasching PA, Engel S, Baumann R, et al. Evaluation of clinical parameters and estrogen receptor alpha gene polymorphisms for patients with endometriosis. Reproduction. 2006;131:153–161
  10. Kim SH, Choi YM, Jun JK, Kim SH, Kim JG, Moon SY. Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis. Fertil Steril. 2005;84:774–777
  11. Iwabe T, Harada T, Terakawa N. Role of cytokines in endometriosis-associated infertility. Gynecol Obstet Invest. 2002;53:19–25
  12. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49:285–296
  13. Punnonen J, Teisala K, Ranta H, Bennett B, Punnonen R. Increased levels of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis. Am J Obstet Gynecol. 1996;174:1522–1526
  14. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Yang YS. Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis. Hum Reprod. 1997;12:2528–2533
  15. Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril. 1996;65:925–930
  16. McLaren J, Dealtry G, Prentice A, Charnock-Jones DS, Smith SK. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum Reprod. 1997;12:1307–1310
  17. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 1997;349:170–173
  18. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46:120–128
  19. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8
  20. Kitawaki J, Obayashi H, Ohta M, Kado N, Ishihara H, Koshiba H, et al. Genetic contribution of the interleukin-10 promoter polymorphism in endometriosis susceptibility. Am J Reprod Immunol. 2002;47:12–18
  21. Albuquerque AG, Moraes M, Vanderborght PR, Romero M, Santos AR, Moraes MO, et al. Tumor necrosis factor and interleukin-10 gene promoter polymorphisms in Brazilian population and in Terena Indians. Transplant Proc. 2004;36:825–826
  22. Zhang X, Hei P, Deng L, Lin J. Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod. 2007;13:135–140
  23. Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet. 2003;33:518–521
  24. Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet. 2005;37:1243–1246
  25. Weir BS, Cardon LR, Anderson AD, Nielsen DM, Hill WG. Measures of human population structure show heterogeneity among genomic regions. Genome Res. 2005;15:1468–1476
  26. Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D, Maruo T. Polymorphisms in estrogen receptor beta but not estrogen receptor alpha affect the risk of developing endometriosis in a Japanese population. Fertil Steril. 2004;81:1650–1656
  27. Georgiou I, Syrrou M, Bouba I, Dalkalitsis N, Paschopoulos M, Navrozoglou I, et al. Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril. 1999;72:164–166
  28. Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone. 1997;21:379–383
  29. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83:149–155
  30. Massart F, Becherini L, Gennari L, Facchini V, Genazzani AR, Brandi ML. Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas. Fertil Steril. 2001;75:567–570
  31. Weiderpass E, Persson I, Melhus H, Wedrén S, Kindmark A, Baron JA. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis. 2000;4:623–627
  32. Zondervan KT, Yudkin PL, Vessey MP, Jenkinson CP, Dawes MG, Barlow DH, et al. The community prevalence of chronic pelvic pain in women and associated illness behaviour. Br J Gen Pract. 2001;51:541–547
  33. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24:235–258
  34. Lalani I, Bhol K, Ahmed AR. Interleukin-10: biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol. 1997;79:469–483
  35. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8
  36. Brinton DA, Quattrociocchi-Longe TM, Kiechle FL. Endometriosis: identification by carbonic anhydrase autoantibodies and clinical features. Ann Clin Lab Sci. 1996;26:409–420
  37. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999;30:526–530
  38. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol. 1997;24:2314–2317
  39. Crawley E, Kay R, Sillibourne J, Pated P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42:1101–1108
  40. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of japan. Cytokine. 2006;34:24–31
  41. Scarpelli D, Cardellini M, Andreozzi F, Laratta E, Hribal ML, Marini MA, et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes. 2006;55:1529–1533
  42. Ma SL, Tang NL, Lam LC, Chiu HF. The association between promotor polymorphism of interleukin-10 gene and Alzheimer's disease. Neurobiol Aging. 2005;26:1005–1010

 J.X. has nothing to disclose. S.W. has nothing to disclose. B.H. has nothing to disclose. Y.P. has nothing to disclose. Y.L. has nothing to disclose. Q.Z. has nothing to disclose. H.J. has nothing to disclose. J.C. has nothing to disclose.

 Supported by a grant from the Science and Technology Planning Program of Nanjing City, Jiangsu Province, People's Republic of China (200502019).

 J. Xie and S. Wang are co-first authors.

PII: S0015-0282(08)01015-7

doi: 10.1016/j.fertnstert.2008.04.069

Fertility and Sterility
Volume 92, Issue 1 , Pages 54-60 , July 2009

Article Tools